Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
This is a non-inferiority, Phase II, open-label, randomized, parallel trial to evaluate
efficacy and safety of the new intervention (Dapaconazole cream 2%) versus the active control
(Ketoconazole cream 2%) in patients with Tinea Pedis. Study schedule comprises enrollment,
treatment and follow-up visits. Treatment period is 14 days.